SCHEMBL8569099

SCHEMBL8569099

CN1CCN(c2cccc3ccc([O])cc23)CC1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 10/20 0.62
HTR1D P28221 9/20 0.62
HTR1B P28222 9/20 0.62
HTR3A P46098 1/20 0.49
HTR5A P47898 1/20 0.46
DRD2 P14416 2/20 0.45
DRD3 P35462 2/20 0.45
MTNR1B P49286 1/20 0.44
DRD4 P21917 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313298 0.83 HTR1A (0.63) HTR1AHTR1DHTR1BHTR3AHTR5A
SCHEMBL6306922 0.81 HTR5A (0.68) HTR1AHTR1DHTR1BHTR3AHTR5A
SCHEMBL3949525 0.81 HTR1A (0.62) HTR1AHTR1DHTR1BHTR3AHTR5A
SCHEMBL6002177 0.80 HTR1A (0.62) HTR1AHTR1DHTR1BHTR3AHTR5A
SCHEMBL7812700 0.80 HTR1A (0.57) HTR1AHTR1DHTR1BHTR5AMTNR1B
SCHEMBL6000211 0.79 HTR1A (0.75) HTR1AHTR1DHTR1BHTR5ADRD2
SCHEMBL6305872 0.79 HTR1A (0.59) HTR1AHTR1DHTR1BHTR3AHTR5A
SCHEMBL6001695 0.79 HTR1A (0.63) HTR1AHTR1DHTR1BHTR3AHTR5A
Hydrochloric Acid SCHEMBL6306223 0.79 HTR1A (0.56) HTR1AHTR1DHTR1BHTR5AMTNR1B
SCHEMBL7812213 0.79 KDM4E (0.60) HTR1AHTR1DHTR1BHTR5AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821245-A Use of naphthalene derivatives in treating lung carcinoma PFIZER INC. (US) 1998-10-13 US disclosed
US-5789412-A 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR ANTAGONISTS FOR THE CURATIVE OR PREVENTIVE TREATMENT OF PAIN, DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, ANXIETY OR PANIC ATTACK, OR CANCER PIERRE FABRE MEDICAMENT (FR) 1998-08-04 US disclosed